{
 "ticker": "SMRI",
 "name": "Bushido Capital US Equity ETF",
 "issuer": "Sepio Capital",
 "desk": "core",
 "url": "https://etfiq.com/funds/smri",
 "html": "https://etfiq.com/funds/smri",
 "markdown": "https://etfiq.com/funds/smri.md",
 "as_of": "2026-10-09",
 "verdict": "SMRI is actively managed and returned +35.5% over the past year.",
 "category": {
  "id": "stocks",
  "name": "Stocks",
  "label": "Stock ETFs",
  "url": "https://etfiq.com/stocks/",
  "group": {
   "id": "us-stocks",
   "name": "U.S. stocks"
  },
  "segment": {
   "id": "us-mid-value",
   "name": "U.S. mid-cap value",
   "url": "https://etfiq.com/stocks/us-mid-value/"
  },
  "status": "classified",
  "as_of": "2026-10-11",
  "method": "https://etfiq.com/methodology/categories"
 },
 "key_facts": [
  {
   "key": "total_return_1_year",
   "label": "Total return, 1 year",
   "value": "+35.5%",
   "source": null,
   "as_of": "2026-10-09",
   "sentence": "SMRI, total return, 1 year: +35.5%, as of Oct 9, 2026."
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.71%",
   "source": null,
   "as_of": "2026-10-09",
   "sentence": "SMRI, expense ratio: 0.71%, as of Oct 9, 2026."
  },
  {
   "key": "holdings",
   "label": "Holdings",
   "value": "50",
   "source": null,
   "as_of": "2026-10-09",
   "sentence": "SMRI, holdings: 50, as of Oct 9, 2026."
  },
  {
   "key": "below_its_high",
   "label": "Below its high",
   "value": "\u22125.8%",
   "source": null,
   "as_of": "2026-10-09",
   "sentence": "SMRI, below its high: \u22125.8%, as of Oct 9, 2026."
  },
  {
   "key": "12_month_yield_cash_paid_1_year_on_its_starting_price",
   "label": "12-month yield: cash paid, 1 year, on its starting price",
   "value": "1.9%",
   "source": null,
   "as_of": "2026-10-09",
   "sentence": "SMRI, 12-month yield: cash paid, 1 year, on its starting price: 1.9%, as of Oct 9, 2026."
  },
  {
   "key": "last_payment",
   "label": "Last payment (paid quarterly), ex-date Sep 28, 2026",
   "value": "$0.4378",
   "source": null,
   "as_of": "2026-10-09",
   "sentence": "SMRI, last payment (paid quarterly), ex-date Sep 28, 2026: $0.4378, as of Oct 9, 2026."
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$644m",
   "source": "SEC filing, whole fund, as filed for Jul 31, 2026",
   "as_of": "2026-10-09",
   "sentence": "SMRI, net assets: $644m (SEC filing, whole fund, as filed for Jul 31, 2026)."
  }
 ],
 "fields": [
  {
   "key": "what_it_tracks",
   "label": "What it tracks",
   "value": "No index, actively managed",
   "source": null
  },
  {
   "key": "fund_type",
   "label": "Fund type",
   "value": "Equity fund",
   "source": null
  },
  {
   "key": "category",
   "label": "Category",
   "value": "Stocks \u00b7 U.S. mid-cap value",
   "source": "ETFIQ"
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.71%",
   "source": "485BPOS XBRL, Nov 20, 2025"
  },
  {
   "key": "price",
   "label": "Price",
   "value": "$45.97",
   "source": null
  },
  {
   "key": "first_traded",
   "label": "First traded",
   "value": "Sep 14, 2023",
   "source": null
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$644m",
   "source": "SEC filing, whole fund, as filed for Jul 31, 2026"
  },
  {
   "key": "benchmark",
   "label": "Benchmark",
   "value": "Its own holdings, as of Jul 31, 2026; its prospectus names no index it tracks",
   "source": "ETFIQ, from its filings"
  },
  {
   "key": "below_its_high",
   "label": "Below its high",
   "value": "\u22125.8%",
   "source": "ETFIQ"
  },
  {
   "key": "holdings",
   "label": "Holdings",
   "value": "50",
   "source": null
  },
  {
   "key": "top_ten_weight",
   "label": "Top ten weight",
   "value": "23.4%",
   "source": null
  },
  {
   "key": "holdings_as_of",
   "label": "Holdings as of",
   "value": "Jul 31, 2026",
   "source": "SEC N-PORT"
  },
  {
   "key": "already_in_the_s_p_500_by_weight",
   "label": "Already in the S&P 500, by weight",
   "value": "83.9%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "95.2%",
   "source": "ETFIQ"
  },
  {
   "key": "already_in_the_nasdaq_100_by_weight",
   "label": "Already in the Nasdaq-100, by weight",
   "value": "25.9%",
   "source": "ETFIQ"
  }
 ],
 "periods": [
  {
   "window": "1 month",
   "Total return": "\u22122.4%",
   "S&P 500 (SPY)": "+2.4%",
   "Gap to SPY": "\u22124.8 pts"
  },
  {
   "window": "3 months",
   "Total return": "+9.6%",
   "S&P 500 (SPY)": "+3.4%",
   "Gap to SPY": "+6.3 pts"
  },
  {
   "window": "6 months",
   "Total return": "+30.6%",
   "S&P 500 (SPY)": "+15.2%",
   "Gap to SPY": "+15.5 pts"
  },
  {
   "window": "Year to date",
   "Total return": "+28.8%",
   "S&P 500 (SPY)": "+15.1%",
   "Gap to SPY": "+13.7 pts"
  },
  {
   "window": "1 year",
   "Total return": "+35.5%",
   "S&P 500 (SPY)": "+17.3%",
   "Gap to SPY": "+18.2 pts"
  },
  {
   "window": "3 years",
   "Total return": "+95.3%",
   "S&P 500 (SPY)": "+85.8%",
   "Gap to SPY": "+9.5 pts"
  },
  {
   "window": "Since launch",
   "Total return": "+89.4%",
   "S&P 500 (SPY)": "+79.9%",
   "Gap to SPY": "+9.5 pts"
  }
 ],
 "questions": [
  {
   "q": "How has SMRI performed?",
   "a": "Over the year to Oct 9, 2026, SMRI returned +35.5% with distributions reinvested, against +17.3% for the S&P 500. Over three years the figure is +95.3%."
  },
  {
   "q": "What does SMRI cost?",
   "a": "The prospectus expense ratio is 0.71% a year."
  },
  {
   "q": "What does SMRI hold?",
   "a": "50 positions as filed for Jul 31, 2026, with the top ten at 23.4% of the fund. 84% of its weight is in stocks the S&P 500 also holds."
  },
  {
   "q": "How far is SMRI below its high?",
   "a": "5.8% below its high of Sep 3, 2026, measured on the reinvested series to Oct 9, 2026."
  }
 ],
 "generated": "2026-10-11",
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, SMRI, stock fund, data as of Oct 9, 2026. https://etfiq.com/funds/smri"
}